High prevalence of latent tuberculosis infection in dialysis patients using the interferon-γ release assay and tuberculin skin test

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 8, 2010, Pages 1451-1457

  Lee, Susan Shin Jung ^a,b   Chou, Kang Ju ^a,b   Dou, Horng Yunn ^c   Huang, Tsi Shu ^a,d   Ni, Yen Yun ^a   Fang, Hua Chang ^a,b   Tsai, Hung Chin ^a,b   Sy, Cheng Len ^a,b   Chen, Jui Kuang ^a,b   Wu, Kuang Sheng ^a,b   Wang, Yung Hsin ^a,b   Lin, Hsi Hsun ^b,e   Chen, Yao Shen ^a,b,f  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d FOOYIN UNIVERSITY   (Taiwan)

^e E DA HOSPITAL   (Taiwan)

^f NATIONAL KAOHSIUNG NORMAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; TAIWAN; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BCG VACCINE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; KIDNEY FAILURE, CHRONIC; LATENT TUBERCULOSIS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TAIWAN; TUBERCULIN TEST; YOUNG ADULT;

EID: 77955721390     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01790210     Document Type: Article

References (39)

1. Global Tuberculosis Control 2009: Epidemiology, Strategy, Financing, Geneva, Switzerland, World Health Organization Press, 2009
2. Taiwan Tuberculosis Control Report 2009, Taipei, Taiwan, Centers for Disease Control, 2009
3. U.S. Renal Data System: USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008
4. Chou KJ, Fang HC, Bai KJ, Hwang SJ, Yang WC, Chung HM: Tuberculosis in maintenance dialysis patients. Nephron 88: 138-143, 2001
5. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I: Disturbances of acquired immunity in hemodialysis patients. Semin Dial 20: 440-451, 2007
6. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M: A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335: 1941-1949, 1996
7. Lundin AP, Adler AJ, Berlyne GM, Friedman EA: Tuberculosis in patients undergoing maintenance hemodialysis. Am J Med 67: 597-602, 1979
8. Chia S, Karim M, Elwood RK, FitzGerald JM: Risk of tuberculosis in dialysis patients: A population-based study. Int J Tuberc Lung Dis 2: 989-991, 1998
9. Centers for Disease Control: Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161: S221-S247, 2000
10. Smirnoff M, Patt C, Seckler B, Adler JJ: Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 113: 25-27, 1998
11. Tuberculosis transmission in a renal dialysis center - Nevada, 2003. MMWR Morb Mortal Wkly Rep 53: 873-875, 2004
12. Sester U, Junker H, Hodapp T, Schutz A, Thiele B, Meyerhans A, Kohler H, Sester M: Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy. Nephrol Dial Transplant 21: 3258-3268, 2006
13. Fang HC, Lee PT, Chen CL, Wu MJ, Chou KJ, Chung HM: Tuberculosis in patients with end-stage renal disease. Int J Tuberc Lung Dis 8: 92-97, 2004
14. Yanai M, Uehara Y, Takeuchi M, Nagura Y, Hoshino T, Hayashi K, Kumasaka K: Evaluation of serological diagnosis tests for tuberculosis in hemodialysis patients. Ther Apher Dial 10: 278-281, 2006
15. Sester M, Sester U, Clauer P, Heine G, Mack U, Moll T, Sybrecht GW, Lalvani A, Kohler H: Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int 65: 1826-1834, 2004
16. Woeltje KF, Mathew A, Rothstein M, Seiler S, Fraser VJ: Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis 31: 848-852, 1998
17. Shankar MS, Aravindan AN, Sohal PM, Kohli HS, Sud K, Gupta KL, Sakhuja V, Jha V: The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: Tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant 20: 2720-2724, 2005
18. Menzies D, Pai M, Comstock G: Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Intern Med 146: 340-354, 2007
19. Pai M, Zwerling A, Menzies D: Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med 149: 177-184, 2008
20. Pai M, Riley LW, Colford JM Jr: Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review. Lancet Infect Dis 4: 761-776, 2004
21. Richeldi L, Losi M, D'Amico R, Luppi M, Ferrari A, Mussini C, Codeluppi M, Cocchi S, Prati F, Paci V, Meacci M, Meccugni B, Rumpianesi F, Roversi P, Cerri S, Luppi F, Ferrara G, Latorre I, Gerunda GE, Torelli G, Esposito R, Fabbri LM: Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 136: 198-204, 2009
22. Stephan C, Wolf T, Goetsch U, Bellinger O, Nisius G, Oremek G, Rakus Z, Gottschalk R, Stark S, Brodt HR, Staszewski S: Comparing QuantiFERON- tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 22: 2471-2479, 2008
23. Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, Perich R, Sanchez-Torres A, Pastor C, Sanchez-Schwartz C, Medina M, Gamboa R, Ugarte M: Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol 35: 776-781, 2008
24. Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M: Detecting latent tuberculosis infection in hemodialysis patients: A head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol 2: 68-73, 2007
25. Winthrop KL, Nyendak M, Calvet H, Oh P, Lo M, Swarbrick G, Johnson C, Lewinsohn DA, Lewinsohn DM, Mazurek GH: Interferon-gamma release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 3: 1357-1363, 2008
26. Triverio PA, Bridevaux PO, Roux-Lombard P, Niksic L, Rochat T, Martin PY, Saudan P, Janssens JP: Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant 24: 1952-1956, 2009
27. Inoue T, Nakamura T, Katsuma A, Masumoto S, Minami E, Katagiri D, Hoshino T, Shibata M, Tada M, Hinoshita F: The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients. Nephrol Dial Transplant 24: 2252-2257, 2009
28. Lee SS, Chou KJ, Su IJ, Chen YS, Fang HC, Huang TS, Tsai HC, Wann SR, Lin HH, Liu YC: High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection 37: 96-102, 2009
29. QuantiFERON®-TB Gold Analysis Software, Carnegie, Australia, Cellestis Ltd., 2009
30. QuantiFERON®-TB Gold In-Tube [package insert]. Carnegie, Australia, Cellestis Ltd., 2009
31. Menzies R, Vissandjee B, Rocher I, St Germain Y: The booster effect in two-step tuberculin testing among young adults in Montreal. Ann Intern Med 120: 190-198, 1994
32. Menzies D: Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 159: 15-21, 1999
33. Landis JR, Koch GG: An application of hierarchical kappatype statistics in the assessment of majority agreement among multiple observers. Biometrics 33: 363-374, 1977
34. Inoue T, Nakamura T, Katsuma A, Masumoto S, Minami E, Katagiri D, Hoshino T, Shibata M, Tada M, Hinoshita F: The value of QuantiFERON(R)TB-Gold in the diagnosis of tuberculosis among dialysis patients. Nephrol Dial Transplant, 24: 2605-2606, 2009
35. Frost WH: The age selection of mortality from tuberculosis in successive decades. Am J Hygiene 30: 91-96, 1939
36. Nelson KE: Epidemiology of infectious diseases: General principles. In: Infectious Disease Epidemiology: Theory and Practice, edited by Nelson KE, Williams CM, Sudbury, MA, Jones and Bartlett Publishers, 2007: 52-53
37. Martin-Malo A, Carracedo J, Ramirez R, Rodriguez-Benot A, Soriano S, Rodriguez M, Aljama P: Effect of uremia and dialysis modality on mononuclear cell apoptosis. J Am Soc Nephrol 11: 936-942, 2000
38. Kobashi Y, Sugiu T, Mouri K, Obase Y, Miyashita N, Oka M: Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur Respir J 33: 812-815, 2009
39. Haustein T, Ridout DA, Hartley JC, Thaker U, Shingadia D, Klein NJ, Novelli V, Dixon GL: The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J 28: 669-673, 2009